Joel Isaacson & Co’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.14M | Sell |
2,281
-203
| -8% | -$97.5K | 0.03% | 186 |
|
|
2026
Q1 | $1.22M | Sell |
2,484
-37
| -1% | -$20.1K | 0.04% | 174 |
|
|
2025
Q4 | $1.46M | Hold |
2,521
| – | – | 0.05% | 159 |
|
|
2025
Q3 | $1.22M | Hold |
2,521
| – | – | 0.04% | 159 |
|
|
2025
Q2 | $1.02M | Sell |
2,521
-345
| -12% | -$144K | 0.04% | 170 |
|
|
2025
Q1 | $1.43M | Buy |
2,866
+51
| +2% | +$27.6K | 0.06% | 123 |
|
|
2024
Q4 | $1.46M | Buy |
2,815
+17
| +0.6% | +$9.35K | 0.07% | 118 |
|
|
2024
Q3 | $1.73M | Buy |
2,798
+77
| +3% | +$45.6K | 0.08% | 104 |
|
|
2024
Q2 | $1.5M | Hold |
2,721
| – | – | 0.08% | 105 |
|
|
2024
Q1 | $1.58M | Buy |
2,721
+1,115
| +69% | +$626K | 0.09% | 102 |
|
|
2023
Q4 | $852K | Sell |
1,606
-10
| -0.6% | -$4.84K | 0.05% | 141 |
|
|
2023
Q3 | $818K | Sell |
1,616
-25
| -2% | -$13.3K | 0.06% | 133 |
|
|
2023
Q2 | $856K | Hold |
1,641
| – | – | 0.06% | 135 |
|
|
2023
Q1 | $946K | Sell |
1,641
-60
| -4% | -$33.8K | 0.07% | 122 |
|
|
2022
Q4 | $937K | Buy |
1,701
+60
| +4% | +$31.8K | 0.07% | 118 |
|
|
2022
Q3 | $832K | Buy |
1,641
+275
| +20% | +$154K | 0.07% | 118 |
|
|
2022
Q2 | $742K | Buy |
1,366
+8
| +0.6% | +$4.4K | 0.06% | 125 |
|
|
2022
Q1 | $777K | Buy |
1,358
+3
| +0.2% | +$1.72K | 0.06% | 132 |
|
|
2021
Q4 | $904K | Buy |
1,355
+4
| +0.3% | +$2.5K | 0.06% | 129 |
|
|
2021
Q3 | $772K | Buy |
1,351
+184
| +16% | +$101K | 0.06% | 138 |
|
|
2021
Q2 | $589K | Buy |
1,167
+50
| +4% | +$23.6K | 0.05% | 158 |
|
|
2021
Q1 | $510K | Buy |
1,117
+200
| +22% | +$95.5K | 0.04% | 153 |
|
|
2020
Q4 | $427K | Buy |
917
+11
| +1% | +$5.16K | 0.04% | 158 |
|
|
2020
Q3 | $400K | Hold |
906
| – | – | 0.05% | 146 |
|
|
2020
Q2 | $328K | Buy |
+906
| New | +$304K | 0.05% | 156 |
|
|
2016
Q4 | – | Sell |
-500
| Closed | -$80K | – | 703 |
|
|
2016
Q3 | $80K | Hold |
500
| – | – | 0.02% | 261 |
|
|
2016
Q2 | $74K | Hold |
500
| – | – | 0.02% | 270 |
|
|
2016
Q1 | $71K | Hold |
500
| – | – | 0.02% | 286 |
|
|
2015
Q4 | $71K | Hold |
500
| – | – | 0.02% | 273 |
|
|
2015
Q3 | $61K | Hold |
500
| – | – | 0.02% | 307 |
|
|
2015
Q2 | $65K | Hold |
500
| – | – | 0.02% | 326 |
|
|
2015
Q1 | $67K | Hold |
500
| – | – | 0.02% | 320 |
|
|
2014
Q4 | $63K | Sell |
500
-500
| -50% | -$60.8K | 0.02% | 295 |
|
|
2014
Q3 | $122K | Hold |
1,000
| – | – | 0.04% | 183 |
|
|
2014
Q2 | $118K | Hold |
1,000
| – | – | 0.04% | 186 |
|
|
2014
Q1 | $120K | Hold |
1,000
| – | – | 0.04% | 182 |
|
|
2013
Q4 | $111K | Hold |
1,000
| – | – | 0.04% | 177 |
|
|
2013
Q3 | $92K | Buy |
1,000
+500
| +100% | +$45.2K | 0.04% | 182 |
|
|
2013
Q2 | $42K | Buy |
+500
| New | +$41.6K | 0.02% | 247 |
|
Other funds holding TMO
Joel Isaacson & Co's TMO Position: Q2 2026 in Review
Joel Isaacson & Co reduced its Thermo Fisher Scientific (TMO) stake by 8.2% in Q2 2026, selling an estimated $97.5K and leaving 2,281 shares worth $1.14M. The position accounts for 0.03% of the portfolio, ranked #186.
Joel Isaacson & Co first reported a position in TMO in Q2 2013 and has held it in 39 quarters since. The position peaked at $1.73M in Q3 2024. 1,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Joel Isaacson & Co held 2,281 shares of Thermo Fisher Scientific worth $1.14M as of Q2 2026.
- Joel Isaacson & Co sold 203 Thermo Fisher Scientific shares in Q2 2026, an estimated $97.5K.
- Thermo Fisher Scientific made up 0.03% of Joel Isaacson & Co's portfolio in Q2 2026, its #186 holding.
- Joel Isaacson & Co first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 39 quarters since.
- Joel Isaacson & Co's Thermo Fisher Scientific position peaked at $1.73M in Q3 2024.
- 1,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Joel Isaacson & Co's 13F filing for Q2 2026, filed 4 Aug 2026.